Literature DB >> 27726003

The Immunobiology of Immunoglobulin G4 and Complement Activation Pathways in IgG4-Related Disease.

Shigeyuki Kawa1.   

Abstract

High serum immunoglobulin (Ig) G4 concentration and abundant IgG4-bearing plasma cell infiltration are characteristic features in autoimmune pancreatitis (AIP). AIP is also complicated with a variety of other organ involvements that commonly share marked IgG4-bearing plasma cell infiltration, suggesting the existence of a systemic disease associated with IgG4 currently recognized as IgG4-related disease (IgG4-RD). However, it is controversial whether IgG4 plays a role in the pathogenesis of AIP or IgG4-RD through such characteristic attributes as Fab-arm exchange and rheumatoid factor (RF)-like activity. Hypocomplementemia has been observed in AIP and several other IgG4-RDs. Muraki et al. reported that complements C3 and C4 were decreased in 36 % of patients with AIP, which implicated the complement activation system in disease pathogenesis. AIP patients with a high level of immune complexes showed serum elevation of IgG4-type immune complexes in an active disease stage, elevated serum IgG1 concentration, and decreased C3 and C4 values. This inferred that while IgG4 may have had little contribution to complement activation, IgG1 played a prominent role via the classical pathway. On the other hand, Sugimoto et al. observed that polyethylene glycol-precipitated immune complexes from patients with IgG4-RD and hypocomplementemia had the ability to activate the complement system through both the classical and the mannose-binding lectin pathways and that IgG4 might participate in the complement activation system. Thus, debate continues on which complement activation systems are working in AIP and IgG4-RD and whether they are associated with the pathogenesis of these conditions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27726003     DOI: 10.1007/82_2016_39

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  11 in total

Review 1.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

Review 2.  Diagnostic and treatment workup for IgG4-related disease.

Authors:  Mary Abraham; Arezou Khosroshahi
Journal:  Expert Rev Clin Immunol       Date:  2017-07-24       Impact factor: 4.473

Review 3.  The Immunologic Paradoxes of IgG4-Related Disease.

Authors:  Xiao Xiao; Min Lian; Weici Zhang; M Eric Gershwin; Xiong Ma
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

4.  Serum immunoglobulin G4 in Sjögren's syndrome: a pilot study.

Authors:  Maria Maślińska; Bożena Wojciechowska; Małgorzata Mańczak; Brygida Kwiatkowska
Journal:  Rheumatol Int       Date:  2020-02-15       Impact factor: 2.631

5.  Prognostic factors in IgG4-related disease: a long-term monocentric Chinese cohort study.

Authors:  Ji Zongfei; Ma Lingying; Zhang Lijuan; Sun Ying; Chen Rongyi; Liu Dongmei; Kong Xiufang; Dai Xiaomin; Ma Lili; Chen Huiyong; Jiang Lindi
Journal:  Clin Rheumatol       Date:  2020-11-05       Impact factor: 2.980

Review 6.  IgG4-related Disease - A Systemic Disease that Deserves Attention Regardless of One's Subspecialty.

Authors:  Hideaki Hamano; Eiji Tanaka; Nobukazu Ishizaka; Shigeyuki Kawa
Journal:  Intern Med       Date:  2017-12-27       Impact factor: 1.271

7.  Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study.

Authors:  Linyi Peng; Hui Lu; Jiaxin Zhou; Panpan Zhang; Jieqiong Li; Zheng Liu; Di Wu; Shangzhu Zhang; Yunjiao Yang; Wei Bai; Li Wang; Yunyun Fei; Wen Zhang; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang
Journal:  Arthritis Res Ther       Date:  2021-04-07       Impact factor: 5.156

Review 8.  The Role of IgG4 in Autoimmunity and Rheumatic Diseases.

Authors:  Maria Maslinska; Joanna Dmowska-Chalaba; Michal Jakubaszek
Journal:  Front Immunol       Date:  2022-01-25       Impact factor: 7.561

9.  Spontaneous Regression of Swollen Submandibular Glands in IgG4-Related Disease.

Authors:  Masanobu Suzuki; Yuji Nakamaru; Dai Takagi; Aya Honma; Takayoshi Suzuki; Emi Takakuwa; Shinya Morita; Sarah Vreugde; Akihiro Homma
Journal:  Allergy Rhinol (Providence)       Date:  2019-05-02

10.  Eculizumab versus rituximab in generalised myasthenia gravis.

Authors:  Christopher Nelke; Christina B Schroeter; Frauke Stascheit; Marc Pawlitzki; Liesa Regner-Nelke; Niklas Huntemann; Ercan Arat; Menekse Öztürk; Nico Melzer; Philipp Mergenthaler; Asmae Gassa; Henning Stetefeld; Michael Schroeter; Benjamin Berger; Andreas Totzeck; Tim Hagenacker; Stefanie Schreiber; Stefan Vielhaber; Hans-Peter Hartung; Andreas Meisel; Heinz Wiendl; Sven G Meuth; Tobias Ruck
Journal:  J Neurol Neurosurg Psychiatry       Date:  2022-03-04       Impact factor: 13.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.